Biotricity Inc. announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists' patient use - Bioflux® and BiotresTM. The distribution agreement covers Bioflux and Biotres and will be distributed directly to hospitals and clinics for professional medical utilization with suitable patients.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | -2.42% | +14.81% | +5.22% |
04-26 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
04-19 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
+5.22% | 14.33M | |
-18.30% | 2.82B | |
-15.42% | 80.71M | |
+10.14% | 50.66M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. Signs Distribution Agreement with Top 5 Distributor for Its Cardiac Monitoring Solutions